Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

US Top Rating Updates on 9/28: NFLX, LMT, ILMN, BIIB and More

avatar
Analysts Notebook wrote a column · Sep 28, 2022 07:12
US Top Rating Updates on 9/28: NFLX, LMT, ILMN, BIIB and More
Netflix Upgraded to Overweight From Neutral at Atlantic Equities
Atlantic Equities analyst Hamilton Faber upgraded $Netflix(NFLX.US)$ to Overweight from Neutral with a price target of $283, up from $211. The upcoming advertising-supported service launch "could be extremely material" and its benefit hasn't been reflected in consensus estimates, Faber tells investors in a research note.
Wells Fargo Downgrades Lockheed to Sell, Says Will 'Under-grow' Peers
Wells Fargo analyst Matthew Akers downgraded $Lockheed Martin(LMT.US)$ to Underweight from Equal Weight with a price target of $415, up from $406. While the bull case for defense "seems clear" with geopolitical tensions high and politicians discussing higher defense spending, 2023 sets up as a "difficult U.S. budget environment, with significant downside potential if tensions ease," Akers tells investors in a research note.
Biogen Upgraded to Buy From Neutral at Mizuho
Mizuho analyst Salim Syed upgraded $Biogen(BIIB.US)$ to Buy from Neutral with a price target of $270, up from $207, following the positive CLARITY AD trial data in early Alzheimer's disease patients. The analyst now assumes $8B, up from $6, in end-user, non-risk-adjusted worldwide peak sales for lecanemab, which is pre-50/50 profit split between Biogen and Eisai.
Source: Seeking Alpha, The Fly
Disclaimer: The content should not be relied on as advice or recommendation.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more
1
14
+0
1
Translate
Report
120K Views
Comment
Sign in to post a comment
avatar
Moomoo News Official Account
How do analysts evaluate the market?
14KFollowers
8Following
34KVisitors
Follow